Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2024. "2024 was an outstanding year for Tenet characterized ...

Researchers suggested that policymakers encourage reinvestment of capital into patient care and limit share buybacks based on the findings.

Management emphasized three strategic priorities for 2025: driving mid-single-digit revenue growth, managing costs with a target of 86% for cost of services and 8.5%-9.5% for SG&A, and optimizing cash ...

Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.